These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 18463734)

  • 1. HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model.
    Rai M; Soragni E; Jenssen K; Burnett R; Herman D; Coppola G; Geschwind DH; Gottesfeld JM; Pandolfo M
    PLoS One; 2008 Apr; 3(4):e1958. PubMed ID: 18463734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.
    Herman D; Jenssen K; Burnett R; Soragni E; Perlman SL; Gottesfeld JM
    Nat Chem Biol; 2006 Oct; 2(10):551-8. PubMed ID: 16921367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich's ataxia patients and in a mouse model.
    Rai M; Soragni E; Chou CJ; Barnes G; Jones S; Rusche JR; Gottesfeld JM; Pandolfo M
    PLoS One; 2010 Jan; 5(1):e8825. PubMed ID: 20098685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3.
    Chan PK; Torres R; Yandim C; Law PP; Khadayate S; Mauri M; Grosan C; Chapman-Rothe N; Giunti P; Pook M; Festenstein R
    Hum Mol Genet; 2013 Jul; 22(13):2662-75. PubMed ID: 23474817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
    Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
    Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
    Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia.
    Plasterer HL; Deutsch EC; Belmonte M; Egan E; Lynch DR; Rusche JR
    PLoS One; 2013; 8(5):e63958. PubMed ID: 23691127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the gene in Friedreich ataxia.
    Hebert MD
    Biochimie; 2008 Aug; 90(8):1131-9. PubMed ID: 18206656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.
    Medina-Carbonero M; Sanz-Alcázar A; Britti E; Delaspre F; Cabiscol E; Ros J; Tamarit J
    Cell Mol Life Sci; 2022 Jan; 79(2):74. PubMed ID: 35038030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
    Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
    Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model.
    Sandi C; Pinto RM; Al-Mahdawi S; Ezzatizadeh V; Barnes G; Jones S; Rusche JR; Gottesfeld JM; Pook MA
    Neurobiol Dis; 2011 Jun; 42(3):496-505. PubMed ID: 21397024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia.
    Greene E; Mahishi L; Entezam A; Kumari D; Usdin K
    Nucleic Acids Res; 2007; 35(10):3383-90. PubMed ID: 17478498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long intronic GAA*TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia.
    Soragni E; Herman D; Dent SY; Gottesfeld JM; Wells RD; Napierala M
    Nucleic Acids Res; 2008 Nov; 36(19):6056-65. PubMed ID: 18820300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia.
    Soragni E; Xu C; Plasterer HL; Jacques V; Rusche JR; Gottesfeld JM
    J Child Neurol; 2012 Sep; 27(9):1164-73. PubMed ID: 22764181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frataxin gene point mutations in Italian Friedreich ataxia patients.
    Gellera C; Castellotti B; Mariotti C; Mineri R; Seveso V; Didonato S; Taroni F
    Neurogenetics; 2007 Nov; 8(4):289-99. PubMed ID: 17703324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friedreich ataxia: Detection of GAA repeat expansions and frataxin point mutations.
    Pandolfo M
    Methods Mol Med; 2006; 126():197-216. PubMed ID: 16930014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Friedreich's Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.
    Marmolino D; Acquaviva F
    Cerebellum; 2009 Sep; 8(3):245-59. PubMed ID: 19165552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human frataxin is regulated by transcription factors SRF and TFAP2.
    Li K; Singh A; Crooks DR; Dai X; Cong Z; Pan L; Ha D; Rouault TA
    PLoS One; 2010 Aug; 5(8):e12286. PubMed ID: 20808827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules affecting transcription in Friedreich ataxia.
    Gottesfeld JM
    Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.